# A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort

> **NCT01647685** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 21 (estimated)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** Nanocort
- **DRUG:** Methylprednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01647685
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2012-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647685, "A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01647685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*